These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26440382)

  • 21. The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.
    Sivignon A; Bouckaert J; Bernard J; Gouin SG; Barnich N
    Expert Opin Ther Targets; 2017 Sep; 21(9):837-847. PubMed ID: 28762293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists.
    Schönemann W; Cramer J; Mühlethaler T; Fiege B; Silbermann M; Rabbani S; Dätwyler P; Zihlmann P; Jakob RP; Sager CP; Smieško M; Schwardt O; Maier T; Ernst B
    ChemMedChem; 2019 Apr; 14(7):749-757. PubMed ID: 30710416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile.
    Kleeb S; Pang L; Mayer K; Eris D; Sigl A; Preston RC; Zihlmann P; Sharpe T; Jakob RP; Abgottspon D; Hutter AS; Scharenberg M; Jiang X; Navarra G; Rabbani S; Smiesko M; Lüdin N; Bezençon J; Schwardt O; Maier T; Ernst B
    J Med Chem; 2015 Mar; 58(5):2221-39. PubMed ID: 25666045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic properties of carbohydrate-lectin interactions: FimH antagonists.
    Scharenberg M; Jiang X; Pang L; Navarra G; Rabbani S; Binder F; Schwardt O; Ernst B
    ChemMedChem; 2014 Jan; 9(1):78-83. PubMed ID: 24357503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?
    Eris D; Preston RC; Scharenberg M; Hulliger F; Abgottspon D; Pang L; Jiang X; Schwardt O; Ernst B
    Chembiochem; 2016 Jun; 17(11):1012-20. PubMed ID: 26991759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli.
    Gouin SG; Wellens A; Bouckaert J; Kovensky J
    ChemMedChem; 2009 May; 4(5):749-55. PubMed ID: 19343765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. d-Mannose Treatment neither Affects Uropathogenic
    Scribano D; Sarshar M; Prezioso C; Lucarelli M; Angeloni A; Zagaglia C; Palamara AT; Ambrosi C
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31941080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
    Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
    J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J; de Boer AR; Wuhrer M; Bouckaert J
    Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosides.
    Pang L; Kleeb S; Lemme K; Rabbani S; Scharenberg M; Zalewski A; Schädler F; Schwardt O; Ernst B
    ChemMedChem; 2012 Aug; 7(8):1404-22. PubMed ID: 22644941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On-cell saturation transfer difference NMR for the identification of FimH ligands and inhibitors.
    Palmioli A; Sperandeo P; Bertuzzi S; Polissi A; Airoldi C
    Bioorg Chem; 2021 Jul; 112():104876. PubMed ID: 33845337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Ratliff TL
    J Urol; 2005 Sep; 174(3):1150. PubMed ID: 16094085
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for success.
    Jiang X; Abgottspon D; Kleeb S; Rabbani S; Scharenberg M; Wittwer M; Haug M; Schwardt O; Ernst B
    J Med Chem; 2012 May; 55(10):4700-13. PubMed ID: 22519985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uropathogenic virulence factor FimH facilitates binding of uteropathogenic Escherichia coli to canine endometrium.
    Krekeler N; Marenda MS; Browning GF; Holden KM; Charles JA; Wright PJ
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):461-7. PubMed ID: 22554919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation-The Example of FimH.
    Krammer EM; de Ruyck J; Roos G; Bouckaert J; Lensink MF
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29976867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin.
    Touaibia M; Krammer EM; Shiao TC; Yamakawa N; Wang Q; Glinschert A; Papadopoulos A; Mousavifar L; Maes E; Oscarson S; Vergoten G; Lensink MF; Roy R; Bouckaert J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28671638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion.
    Arné P; Marc D; Brée A; Schouler C; Dho-Moulin M
    Avian Dis; 2000; 44(2):343-55. PubMed ID: 10879915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of simulated stages of the canine oestrous cycle on Escherichia coli binding to canine endometrium.
    Krekeler N; Lodge KM; Anderson GA; Browning GF; Charles JA; Wright PJ
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():331-4. PubMed ID: 23279531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heptyl α-D-mannosides grafted on a β-cyclodextrin core to interfere with Escherichia coli adhesion: an in vivo multivalent effect.
    Bouckaert J; Li Z; Xavier C; Almant M; Caveliers V; Lahoutte T; Weeks SD; Kovensky J; Gouin SG
    Chemistry; 2013 Jun; 19(24):7847-55. PubMed ID: 23595913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.